<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" bill-type="olc" dms-id="H6C3A97B584E24E21A6A821DD22101CCC" key="H" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 4739 RH: Synthetic Opioid Exposure Prevention and Training Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2019-10-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">IB</distribution-code>
		<calendar display="yes">Union Calendar No. 259</calendar>
		<congress display="yes">116th CONGRESS</congress><session display="yes">1st Session</session>
		<legis-num display="yes">H. R. 4739</legis-num>
		<associated-doc display="yes" role="report">[Report No. 116–318, Part I]</associated-doc>
		<current-chamber display="yes">IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action display="yes">
			<action-date date="20191018">October 18, 2019</action-date>
			<action-desc><sponsor name-id="C001067">Ms. Clarke of New York</sponsor> (for herself, <cosponsor name-id="T000193">Mr. Thompson of Mississippi</cosponsor>, <cosponsor name-id="R000602">Miss Rice of New York</cosponsor>, <cosponsor name-id="R000613">Mr. Rose of New York</cosponsor>, <cosponsor name-id="K000210">Mr. King of New York</cosponsor>, <cosponsor name-id="K000386">Mr. Katko</cosponsor>, <cosponsor name-id="H001077">Mr. Higgins of Louisiana</cosponsor>, <cosponsor name-id="S001208">Ms. Slotkin</cosponsor>, and <cosponsor name-id="R000575">Mr. Rogers of Alabama</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HHM00">Committee on Homeland Security</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<action><action-date>December 3, 2019</action-date><action-desc>Additional sponsor: <cosponsor name-id="M001157">Mr. McCaul</cosponsor></action-desc></action><action>
			<action-date>December 3, 2019</action-date>
			<action-desc>Reported from the  <committee-name committee-id="HHM00">Committee on Homeland Security</committee-name></action-desc>
		</action>
		<action><action-date>December 3, 2019</action-date><action-desc><committee-name committee-id="HWM00">Committee on Ways and Means</committee-name> discharged; committed to the Committee of the Whole House on the State of the Union and ordered to
			 be printed</action-desc></action><action><action-desc><pagebreak></pagebreak></action-desc></action><legis-type>A BILL</legis-type>
		<official-title display="yes">To amend the Homeland Security Act of 2002 to protect U.S. Customs and Border Protection officers,
			 agents, other personnel, and canines against potential synthetic opioid
			 exposure, and for other purposes.<pagebreak></pagebreak></official-title>
	</form>
	<legis-body id="HA4FC134E85B0454B8EBAE0C46A456149" style="OLC">
 <section id="HE0D3CC2E5FAA411E90252601132849D2" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Synthetic Opioid Exposure Prevention and Training Act</short-title></quote>.</text> </section><section id="HF5F888F53FB94F75BCE1C1ACA9E6ADAC"><enum>2.</enum><header>Protection against potential synthetic opioid exposure within U.S. Customs and Border Protection</header> <subsection id="HAE4CB9DE54E04C9D98B019BF08E8C6C0"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Subtitle B of title IV of the Homeland Security Act of 2002 (<external-xref legal-doc="usc" parsable-cite="usc/6/211">6 U.S.C. 211</external-xref> et seq.) is amended by inserting after section 415 the following new section:</text>
				<quoted-block display-inline="no-display-inline" id="HEDD146E3E1FB4E1EBD17018000AFBBC3" style="OLC">
					<section id="H2013EA1F614A47D1A61AD8870F331570"><enum>416.</enum><header>Protection against potential synthetic opioid exposure</header>
 <subsection id="HD4B655E6D1E544149B1F9F661ABB4BAA"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Commissioner of U.S. Customs and Border Protection shall issue a policy that specifies effective protocols and procedures for the safe handling of potential synthetic opioids, including fentanyl, by U.S. Customs and Border Protection officers, agents, other personnel, and canines, and to reduce the risk of injury or death resulting from accidental exposure and enhance post-exposure management.</text>
						</subsection><subsection id="HED32475FD1D14709B18E4B2CA86CF32A"><enum>(b)</enum><header>Training</header>
 <paragraph id="H58441963746D46678F829D768249EA6C"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall require mandatory and recurrent training on the following:</text>
 <subparagraph id="HF44DBFAD8213434BA807861B49D72BF8"><enum>(A)</enum><text display-inline="yes-display-inline">The potential risk of opioid exposure and safe handling procedures for potential synthetic opioids, including precautionary measures such as the use of personal protective equipment during such handling.</text>
 </subparagraph><subparagraph id="HDC243607D20045708EB3B9E1B39A63CE"><enum>(B)</enum><text display-inline="yes-display-inline">How to access and administer opioid receptor antagonists, including naloxone, post-exposure to potential synthetic opioids.</text>
 </subparagraph></paragraph><paragraph id="H63DF601E095F4CA8BA6E98BBD88E703F"><enum>(2)</enum><header>Integration</header><text display-inline="yes-display-inline">The training described in paragraph (1) may be integrated into existing training under section 411(l) for U.S. Customs and Border Protection officers, agents, and other personnel.</text>
 </paragraph></subsection><subsection id="H2D2DF2BAE2D646FABDAF89B556DEDEF9"><enum>(c)</enum><header>Personal protective equipment and opioid receptor antagonists</header><text display-inline="yes-display-inline">Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall ensure the availability of personal protective equipment and opioid receptor antagonists, including naloxone, to all U.S. Customs and Border Protection officers, agents, other personnel, and canines at risk of accidental exposure to synthetic opioids.</text>
 </subsection><subsection id="H70EBE573E3F44F55B438C585AB8CA427"><enum>(d)</enum><header>Oversight</header><text display-inline="yes-display-inline">To ensure effectiveness of the policy described in subsection (a)—</text> <paragraph id="HF3CCB7167EE1425E9A11763502B6517A"><enum>(1)</enum><text display-inline="yes-display-inline">the Commissioner of U.S. Customs and Border Protection shall regularly monitor the efficacy of the implementation of such policy and adjust protocols and procedures, as necessary; and</text>
 </paragraph><paragraph id="H4D57AB16D84749D29BDF769F91AF6040"><enum>(2)</enum><text display-inline="yes-display-inline">the Inspector General of the Department shall audit compliance with the requirements of this section not less than once each year for the five years after the date of the enactment of this section.</text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
 </subsection><subsection id="HBD6341B2945F421C83622D1B27C929C3"><enum>(b)</enum><header>Clerical amendment</header><text>The table of contents in section 1(b) of the Homeland Security Act of 2002 is amended by inserting after the item relating to section 415 the following new item:</text>
				<quoted-block display-inline="no-display-inline" id="H2DFAD70AEAF54DA7B63D8756EE4F9DBC" style="OLC">
					<toc regeneration="no-regeneration">
						<toc-entry level="section">Sec. 416. Protection against potential synthetic opioid exposure.</toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block>
			</subsection></section></legis-body>
	<endorsement display="yes">
		<action-date>December 3, 2019</action-date>
		<action-desc>Reported from the  <committee-name committee-id="HHM00">Committee on Homeland Security</committee-name></action-desc><action-date>December 3, 2019</action-date><action-desc><committee-name committee-id="HWM00">Committee on Ways and Means</committee-name> discharged; committed to the Committee of the Whole House on the State of the Union and ordered to
			 be printed</action-desc></endorsement>
</bill>


